APA (7th ed.) Citation

WR, L., J, P., JA, W., B, K., L, V., U, S., . . . CB, F. (2024). Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: Effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilization. Frontiers in immunology, 15, 1480976. https://doi.org/10.3389/fimmu.2024.1480976

Chicago Style (17th ed.) Citation

WR, Lykins, et al. "Optimizing Immunogenicity and Product Presentation of a SARS-CoV-2 Subunit Vaccine Composition: Effects of Delivery Route, Heterologous Regimens with Self-amplifying RNA Vaccines, and Lyophilization." Frontiers in Immunology 15 (2024): 1480976. https://doi.org/10.3389/fimmu.2024.1480976.

MLA (9th ed.) Citation

WR, Lykins, et al. "Optimizing Immunogenicity and Product Presentation of a SARS-CoV-2 Subunit Vaccine Composition: Effects of Delivery Route, Heterologous Regimens with Self-amplifying RNA Vaccines, and Lyophilization." Frontiers in Immunology, vol. 15, 2024, p. 1480976, https://doi.org/10.3389/fimmu.2024.1480976.